Manufacturing Dopamine in the Brain with Gene Therapy

Share

(August 25, 2016) – Levodopa initially controls symptoms associated with Parkinson’s disease but over time, the drug becomes less effective. A biotech company based in Cambridge, MA called Voyager Therapeutics now thinks it can extend the effects of L-Dopa by using gene therapy. Read more…

Click for a printer friendly version

Back to top